ProteopediaMain Page | About | Help | FAQ | Special pages | Log in

Printable version | Disclaimers | Privacy policy | Current revision

Journal:Protein Science:2

(Difference between revisions)

Line 1: Line 1:
-
<StructureSection load='' size='450' side='right' scene='72/725874/Cv/26' caption=''>
+
<StructureSection load='' size='450' side='right' scene='72/725874/Cv/39' caption=''>
===The Impact of Crystallization Conditions on Structure-Based Drug Design: a Case Study on the Methylene Blue/Acetylcholinesterase Complex===
===The Impact of Crystallization Conditions on Structure-Based Drug Design: a Case Study on the Methylene Blue/Acetylcholinesterase Complex===
<big>Orly Dym, Wanling Song, Clifford Felder, Esther Roth, Valery Shnyrov, Yacov, Ashani, Yechun Xu, Robbie P. Joosten, Lev Weiner, Joel L. Sussman, and Israel Silman</big> <ref>PMID:26990888</ref>
<big>Orly Dym, Wanling Song, Clifford Felder, Esther Roth, Valery Shnyrov, Yacov, Ashani, Yechun Xu, Robbie P. Joosten, Lev Weiner, Joel L. Sussman, and Israel Silman</big> <ref>PMID:26990888</ref>

Revision as of 10:32, 12 December 2024

Drag the structure with the mouse to rotate
  1. Dym O, Song W, Felder C, Roth E, Shnyrov V, Ashani Y, Xu Y, Joosten RP, Weiner L, Sussman JL, Silman I. The Impact of Crystallization Conditions on Structure-Based Drug Design: A Case Study on the Methylene Blue/Acetylcholinesterase Complex. Protein Sci. 2016 Mar 14. doi: 10.1002/pro.2923. PMID:26990888 doi:http://dx.doi.org/10.1002/pro.2923

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Joel L. Sussman, Jaime Prilusky